endpts.com·Jun 10, 2026
Shattuck Labs has raised $75 million through a public offering, selling over 10.5 million shares at $4 each. Additionally, Servier has entered into a partnership with the n-Lorem Foundation focused on neuro ASO development.
Shattuck Labs' recent $75 million public offering indicates significant investor interest in their biotech innovations, which could be a signal for potential investment opportunities in companies focused on novel therapeutic approaches. Additionally, Servier's collaboration with the n-Lorem Foundation on neuro ASO (antisense oligonucleotide) therapies highlights the growing importance of partnerships in advancing precision medicine solutions within the biotech sector.